Despite decades of research, development of a treatment for stimulant use disorder remains elusive. Experts are now hunkering down to come with new approaches to overcome hurdles in clinical trial design and the selection of study endpoints.
“I’m quite sure we’ve been doing it wrong. If we had been doing it right, we would have found something...







